Roche has said it plans to UK price its latest multiple sclerosis drug Ocrevus in line with its close rival from Novartis - aiming to undercut some established rivals. Approved in Europe earlier ...
With rituximab, you'd get the medication through an IV in a doctor’s office ... National Multiple Sclerosis Society: "FDA Approves Ocrevus™ (ocrelizumab) for People with Primary Progressive ...
Ocrevus is a medicine commonly used to treat primary progressive MS, but it can take up to four hours to receive intravenously. A new version called “Ocrevus Zunovo” was recently approved by ...
Arizona's largest health system on Monday confirmed it was postponing some surgeries because of a national IV fluid shortage caused by Hurricane Helene. The delays, which took effect Monday ...
As the storm swept through western North Carolina last month, it severely affected operations at Baxter International’s North Cove production site, the largest manufacturer of IV fluids and ...
Even so, the availability of Ocrevus Zunovo should open up opportunities in places where there is no infrastructure for IV administration, and Roche believes this is an incremental opportunity of ...
Hospitals across the United States are reeling from a shortage of IV fluids after Hurricane Helene struck a major manufacturing plant in North Carolina, prompting some to postpone elective ...
Damage to the plant in North Carolina has worsened a nationwide shortage of IV fluids, and hospitals say they are still postponing some surgeries and other procedures as a result. Some 60% of the ...
The surgery was off because there wasn’t enough IV fluid to proceed. “I was having such a hard time processing what she was even saying to me, that I was just really quiet,” she says ...
Approval was granted for all of the adult IV TECENTRIQ indications, with treatment delivered as an approximately 7 minute subcutaneous injection. Roche also received U.S. approval of OCREVUS ...
A shortage of IV fluid in the wake of Hurricane Helene is shining a spotlight on the fragility and vulnerability of the country’s medical supply chain. Hospitals were left scrambling after the ...
The national IV fluid shortage has hit at least one hospital in Boston, which is deferring some non-urgent elective procedures. Mass General Brigham says it is delaying some non-urgent elective ...